CRO (医薬品開発業務受託) サービスの世界市場

世界のCRO (医薬品開発業務受託) サービスの市場規模は、2024年の1,118億米ドルから、予測期間中は8.2%のCAGRで推移し、2029年末には1,660億米ドルに達すると予測されています。

臨床試験の部門は、2024年の841億米ドルから、予測期間中は8.5%のCAGRで推移し、2029年末には1,265億米ドルに達すると予測されています。前臨床研究の部門は、2024年の139億米ドルから、CAGR 8.0％で推移し、2029年末には205億米ドルに達すると予測されています。

当レポートでは、世界のCRO (医薬品開発業務受託) サービスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• 概要
• ポーターのファイブフォース分析

第3章 市場力学

• 市場力学
• 市場促進要因
• CROにおけるAI導入の増加
• バイオテクノロジーおよび製薬企業への研究開発投資
• 慢性疾患および免疫疾患の世界の蔓延
• CROが効率性を高める
• 市場抑制要因
• CROアウトソーシングの課題
• 熟練した専門家の不足
• 市場機会
• 無機的戦略

第4章 規制状況

• FDAの規制と影響
• スポンサー活動に関する規制
• CDISC標準
• BIMOプログラム
• 欧州規格

第5章 新興技術

• 概要
• コンピュータベースの技術
• 分散型臨床試験
• 高度な分析とシミュレーション

第6章 市場セグメンテーション分析

• セグメンテーションの内訳
• 世界のCROサービス市場：機能別
• 世界の市場規模・予測
• 臨床試験
• 前臨床研究
• 創薬
• 中央ラボ
• 世界のCROサービス市場：治療領域別
• 世界の市場規模・予測
• 腫瘍
• 心臓病
• 代謝
• 神経
• 免疫
• その他
• 世界のCROサービス市場：エンドユーザー別
• 世界の市場規模・予測
• バイオ医薬品企業
• 学術研究機関
• 地理的内訳
• 世界のCROサービス市場：地域別
• 世界の市場規模・予測
• 北米
• 欧州
• アジア太平洋
• その他

第7章 競合情報

• 概要
• 競合情勢
• M&A
• SWOT分析

第8章 CROサービス市場における持続可能性：ESGの観点

• ESG：イントロダクション
• CROサービス市場における持続可能性
• ESGの視点
• 環境への影響
• 社会的影響
• ガバナンス

第9章 付録

• 調査手法
• 略語
• 出典
• 企業プロファイル
• CHARLES RIVER LABORATORIES
• FRONTAGE LABS.
• ICON PLC
• IQVIA INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• MEDPACE
• PAREXEL INTERNATIONAL CORP.
• SYNEOS HEALTH
• THERMO FISHER SCIENTIFIC INC.
• WUXI APPTEC

List of Tables

• Summary Table : Global Market for CRO Services, by Functional Services, Through 2029
• Table 1 : Summary of Porter's Five Forces Analysis: CRO Services Market
• Table 2 : Global Market for CRO Services, by Functional Services, Through 2029
• Table 3 : Clinical Trail Illustration
• Table 4 : Clinical Trial Phase Description
• Table 5 : Global Market for CRO Services in Clinical Trials, by Region, Through 2029
• Table 6 : Global Market for CRO Services in Preclinical Research, by Region, Through 2029
• Table 7 : Global Market for CRO Services in Drug Discovery, by Region, Through 2029
• Table 8 : Global Market for CRO Services in Central Laboratories, by Region, Through 2029
• Table 9 : Global Market for CRO Services, by Therapeutic Area, Through 2029
• Table 10 : Global Market for CRO Services in Oncology, by Region, Through 2029
• Table 11 : Global Market for CRO Services in Cardiology, by Region, Through 2029
• Table 12 : Global Market for CRO Services in Metabolic Diseases, by Region, Through 2029
• Table 13 : Global Market for CRO Services in Neurology, by Region, Through 2029
• Table 14 : Global Market for CRO Services in Immunological Disorders, by Region, Through 2029
• Table 15 : Global Market for CRO Services in Other Therapeutic Areas, by Region, Through 2029
• Table 16 : Global Market for CRO Services, by End User, Through 2029
• Table 17 : Global Market for CRO Services in Biopharmaceutical Companies, by Region, Through 2029
• Table 18 : Global Market for CRO Services in Academic Research Institutions, by Region, Through 2029
• Table 19 : Global Market for CRO Services, by Region, Through 2029
• Table 20 : Diabetes Estimates in North America, by Country, 2000-2045
• Table 21 : North American Market for CRO Services, by Functional Services, Through 2029
• Table 22 : North American Market for CRO Services, by Therapeutic Area, Through 2029
• Table 23 : North American Market for CRO Services, by End User, Through 2029
• Table 24 : North American Market for CRO Services, by Country, Through 2029
• Table 25 : U.S. Market for CRO Services, by Functional Services, Through 2029
• Table 26 : U.S. Market for CRO Services, by Therapeutic Area, Through 2029
• Table 27 : U.S. Market for CRO Services, by End User, Through 2029
• Table 28 : Canadian Market for CRO Services, by Functional Services, Through 2029
• Table 29 : Canadian Market for CRO Services, by Therapeutic Area, Through 2029
• Table 30 : Canadian Market for CRO Services, by End User, Through 2029
• Table 31 : Mexican Market for CRO Services, by Functional Services, Through 2029
• Table 32 : Mexican Market for CRO Services, by Therapeutic Area, Through 2029
• Table 33 : Mexican Market for CRO Services, by End User, Through 2029
• Table 34 : Diabetes Estimates for the Top 10 European Countries, 2000-2045
• Table 35 : European Market for CRO Services, by Functional Services, Through 2029
• Table 36 : European Market for CRO Services, by Therapeutic Area, Through 2029
• Table 37 : European Market for CRO Services, by End User, Through 2029
• Table 38 : European Market for CRO Services, by Country, Through 2029
• Table 39 : German Market for CRO Services, by Functional Services, Through 2029
• Table 40 : German Market for CRO Services, by Therapeutic Area, Through 2029
• Table 41 : German Market for CRO Services, by End User, Through 2029
• Table 42 : U.K. Market for CRO Services, by Functional Services, Through 2029
• Table 43 : U.K. Market for CRO Services, by Therapeutic Area, Through 2029
• Table 44 : U.K. Market for CRO Services, by End User, Through 2029
• Table 45 : French Market for CRO Services, by Functional Services, Through 2029
• Table 46 : French Market for CRO Services, by Therapeutic Area, Through 2029
• Table 47 : French Market for CRO Services, by End User, Through 2029
• Table 48 : Rest of the European Market for CRO Services, by Functional Services, Through 2029
• Table 49 : Rest of the European Market for CRO Services, by Therapeutic Area, Through 2029
• Table 50 : Rest of the European Market for CRO Services, by End User, Through 2029
• Table 51 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
• Table 52 : Asia-Pacific Market for CRO Services, by Functional Services, Through 2029
• Table 53 : Asia-Pacific Market for CRO Services, by Therapeutic Area, Through 2029
• Table 54 : Asia-Pacific Market for CRO Services, by End User, Through 2029
• Table 55 : Asia-Pacific Market for CRO Services, by Country, Through 2029
• Table 56 : Chinese Market for CRO Services, by Functional Services, Through 2029
• Table 57 : Chinese Market for CRO Services, by Therapeutic Area, Through 2029
• Table 58 : Chinese Market for CRO Services, by End User, Through 2029
• Table 59 : Japanese Market for CRO Services, by Functional Services, Through 2029
• Table 60 : Japanese Market for CRO Services, by Therapeutic Area, Through 2029
• Table 61 : Japanese Market for CRO Services, by End User, Through 2029
• Table 62 : Indian Market for CRO Services, by Functional Services, Through 2029
• Table 63 : Indian Market for CRO Services, by Therapeutic Area, Through 2029
• Table 64 : Indian Market for CRO Services, by End User, Through 2029
• Table 65 : Rest of Asia-Pacific Market for CRO Services, by Functional Services, Through 2029
• Table 66 : Rest of Asia-Pacific Market for CRO Services, by Therapeutic Area, Through 2029
• Table 67 : Rest of Asia-Pacific Market for CRO Services, by End User, Through 2029
• Table 68 : Rest of the World Market for CRO Services, by Functional Services, Through 2029
• Table 69 : Rest of the World Market for CRO Services, by Therapeutic Area, Through 2029
• Table 70 : Rest of the World Market for CRO Services, by End User, Through 2029
• Table 71 : Rest of the World Market for CRO Services, by Sub-Region, Through 2029
• Table 72 : South American Market for CRO Services, by Functional Services, Through 2029
• Table 73 : South American Market for CRO Services, by Therapeutic Area, Through 2029
• Table 74 : South American Market for CRO Services, by End User, Through 2029
• Table 75 : Middle Eastern and African Market for CRO Services, by Functional Services, Through 2029
• Table 76 : Middle Eastern and African Market for CRO Services, by Therapeutic Area, Through 2029
• Table 77 : Middle Eastern and African Market for CRO Services, by End User, Through 2029
• Table 78 : Service Offerings, Major CROs
• Table 79 : Pharmaceutical and CRO Partnership Alliances
• Table 80 : Recent M&As in CROs Services Market, 2020-2024
• Table 81 : Key ESG Metrics in the CRO Services Market
• Table 82 : ESG Rankings for CRO Services
• Table 83 : Abbreviations Used in this Report
• Table 84 : Report Sources
• Table 85 : Charles River Laboratories: Company Snapshot
• Table 86 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
• Table 87 : Charles River Laboratories: Service Portfolio
• Table 88 : Charles River Laboratories: News/Key Developments, 2021-2024
• Table 89 : Frontage Labs.: Company Snapshot
• Table 90 : Frontage Labs.: Financial Performance, FY 2022 and 2023
• Table 91 : Frontage Labs.: Product Portfolio
• Table 92 : Frontage Labs.: News/Key Development, 2022-2024
• Table 93 : ICON plc: Company Snapshot
• Table 94 : ICON plc: Financial Performance, FY 2022 and 2023
• Table 95 : ICON plc: Product Portfolio
• Table 96 : ICON plc: News/Key Development, 2020-2023
• Table 97 : IQVIA Inc.: Company Snapshot
• Table 98 : IQVIA Inc.: Financial Performance, FY 2022 and 2023
• Table 99 : IQVIA Inc.: Service Portfolio
• Table 100 : IQVIA Inc.: News/Key Developments, 2024
• Table 101 : Laboratory Corporation of America Holdings: Company Snapshot
• Table 102 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
• Table 103 : Laboratory Corporation of America Holdings: Service Portfolio
• Table 104 : Laboratory Corporation of America Holdings: News/Key Developments, 2024
• Table 105 : Medpace: Company Snapshot
• Table 106 : Medpace: Financial Performance, FY 2022 and 2023
• Table 107 : Medpace: Service Portfolio
• Table 108 : Parexel International Corp.: Company Snapshot
• Table 109 : Parexel International Corp.: Service Portfolio
• Table 110 : Syneos Health: Company Snapshot
• Table 111 : Syneos Health: Service Portfolio
• Table 112 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 113 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 114 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 115 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023
• Table 116 : WuXi AppTec: Company Snapshot
• Table 117 : WuXi AppTec: Financial Performance, FY 2022 and 2023
• Table 118 : WuXi AppTec: Service Portfolio

List of Figures

• Summary Figure : Global Market for CRO Services, by Functional Services, 2021-2029
• Figure 1 : CRO Services: Market Dynamics
• Figure 2 : Global Market Shares of CRO Services, by Functional Services, 2023
• Figure 3 : Overall Phase Transition Success Rates in Biologic Drug Development
• Figure 4 : Phase II Transition Success Rates, by Disease Area, 2021
• Figure 5 : Phase III Transition Success Rates, by Disease Area, 2021
• Figure 6 : Global Market Shares of CRO Services Throughout the Clinical Trial Process, by Phase, 2023
• Figure 7 : Phase IV Transition Success Rates, by Disease Area, 2021
• Figure 8 : Global Market for CRO Services in Clinical Trials, by Region, 2021-2029
• Figure 9 : Global Market for CRO Services in Preclinical Research, by Region, 2021-2029
• Figure 10 : CRO Services Related to Drug Discovery
• Figure 11 : Global Market for CRO Services in Drug Discovery, by Region, 2021-2029
• Figure 12 : Global Market for CRO Services in Central Laboratories, by Region, 2021-2029
• Figure 13 : Global Market Shares of CRO Services, by Therapeutic Area, 2023
• Figure 14 : Global Market Shares of CRO Services in Oncology, by Region, 2023
• Figure 15 : Global Market Shares of CRO Services in Cardiology, by Region, 2023
• Figure 16 : Global Market Shares of CRO Services in Metabolic Diseases, by Region, 2023
• Figure 17 : Global Market Shares of CRO Services in Neurology, by Region, 2023
• Figure 18 : Global Market Shares of CRO Services in Immunological Disorders, by Region, 2023
• Figure 19 : Global Market Shares of CRO Services in Other Therapeutic Areas, by Region, 2023
• Figure 20 : Global Market Shares of CRO Services, by End User, 2023
• Figure 21 : Global Market Shares of CRO Services in Biopharmaceutical companies, by Region, 2023
• Figure 22 : Global Market Shares of CRO Services in Academic Research Institutions, by Region, 2023
• Figure 23 : Global Market for CRO Services, by Region, 2021-2029
• Figure 24 : North American Market for CRO Services, by Functional Services, 2021-2029
• Figure 25 : North American Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 26 : North American Market for CRO Services, by End User, 2021-2029
• Figure 27 : North American Market Shares of CRO Services, by Country, 2023
• Figure 28 : U.S. Market for CRO Services, by Functional Services, 2021-2029
• Figure 29 : U.S. Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 30 : U.S. Market for CRO Services, by End User, 2021-2029
• Figure 31 : Canadian Market for CRO Services, by Functional Services, 2021-2029
• Figure 32 : Canadian Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 33 : Canadian Market for CRO Services, by End User, 2021-2029
• Figure 34 : Mexican Market for CRO Services, by Functional Services, 2021-2029
• Figure 35 : Mexican Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 36 : Mexican Market for CRO Services, by End User, 2021-2029
• Figure 37 : European Market for CRO Services, by Functional Services, 2021-2029
• Figure 38 : European Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 39 : European Market for CRO Services, by End User, 2021-2029
• Figure 40 : European Market Shares of CRO Services, by Country, 2023
• Figure 41 : German Market for CRO Services, by Functional Services, 2021-2029
• Figure 42 : German Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 43 : German Market for CRO Services, by End User, 2021-2029
• Figure 44 : U.K. Market for CRO Services, by Functional Services, 2021-2029
• Figure 45 : U.K. Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 46 : U.K. Market for CRO Services, by End User, 2021-2029
• Figure 47 : French Market for CRO Services, by Functional Services, 2021-2029
• Figure 48 : French Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 49 : French Market for CRO Services, by End User, 2021-2029
• Figure 50 : Rest of the European Market for CRO Services, by Functional Services, 2021-2029
• Figure 51 : Rest of the European Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 52 : Rest of the European Market for CRO Services, by End User, 2021-2029
• Figure 53 : Asia-Pacific Market for CRO Services, by Functional Services, 2021-2029
• Figure 54 : Asia-Pacific Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 55 : Asia-Pacific Market for CRO Services, by End User, 2021-2029
• Figure 56 : Asia-Pacific Market Shares of CRO Services, by Country, 2023
• Figure 57 : Chinese Market for CRO Services, by Functional Services, 2021-2029
• Figure 58 : Chinese Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 59 : Chinese Market for CRO Services, by End User, 2021-2029
• Figure 60 : Japanese Market for CRO Services, by Functional Services, 2021-2029
• Figure 61 : Japanese Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 62 : Japanese Market for CRO Services, by End User, 2021-2029
• Figure 63 : Indian Market for CRO Services, by Functional Services, 2021-2029
• Figure 64 : Indian Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 65 : Indian Market for CRO Services, by End User, 2021-2029
• Figure 66 : Rest of Asia-Pacific Market for CRO Services, by Functional Services, 2021-2029
• Figure 67 : Rest of Asia-Pacific Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 68 : Rest of Asia-Pacific Market for CRO Services, by End User, 2021-2029
• Figure 69 : Rest of the World Market for CRO Services, by Functional Services, 2021-2029
• Figure 70 : Rest of the World Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 71 : Rest of the World Market for CRO Services, by End User, 2021-2029
• Figure 72 : Rest of the World Market Shares of CRO Services, by Sub-Region, 2023
• Figure 73 : South American Market for CRO Services, by Functional Services, 2021-2029
• Figure 74 : South American Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 75 : South American Market for CRO Services, by End User, 2021-2029
• Figure 76 : Middle Eastern and African Market for CRO Services, by Functional Services, 2021-2029
• Figure 77 : Middle Eastern and African Market for CRO Services, by Therapeutic Area, 2021-2029
• Figure 78 : Middle Eastern and African Market for CRO Services, by End User, 2021-2029
• Figure 79 : Global Market Shares of CRO Services, by Company, 2020
• Figure 80 : SWOT Analysis of the CRO Services Market
• Figure 81 : Pillars of ESG
• Figure 82 : Advantages of ESG for CRO Services Companies
• Figure 83 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
• Figure 84 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
• Figure 85 : Frontage Labs.: Revenue Share, by Business Unit, FY 2023
• Figure 86 : Frontage Labs.: Revenue Share, by Country/Region, FY 2023
• Figure 87 : ICON plc: Revenue Share, by Country/Region, FY 2023
• Figure 88 : IQVIA Inc: Revenue Share, by Business Unit, FY 2023
• Figure 89 : IQVIA Inc: Revenue Share, by Country/Region, FY 2023
• Figure 90 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023
• Figure 91 : Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023
• Figure 92 : Medpace: Revenue Share, by Business Unit, FY 2023
• Figure 93 : Medpace: Revenue Share, by Country/Region, FY 2023
• Figure 94 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 95 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 96 : WuXi AppTec: Revenue Share, by Business Unit, FY 2023
• Figure 97 : WuXi AppTec: Revenue Share, by Country/Region, FY 2023

The global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

The global market for clinical trials functional services of CRO is expected to grow from $84.1 billion in 2024 and is projected to reach $126.5 billion by the end of 2029, at a CAGR of 8.5% during the forecast period of 2024 to 2029.

The global market for preclinical research functional services of CRO is expected to grow from $13.9 billion in 2024 and is projected to reach $20.5 billion by the end of 2029, at a CAGR of 8.0% during the forecast period of 2024 to 2029.

Report Scope

This report analyzes the global contract research organization (CRO) services market and will cover all the major global CRO companies. It provides a comprehensive overview of the clinical trial process, including a detailed description of all the phases and functional services CROs associated with clinical trials; and it details the major therapeutic areas covered by CROs and their broad service offerings.

As part of this analysis, the CRO services market is divided by functional services into the following market segments: clinical trials services, preclinical research, drug discovery and central lab. It is segmented by therapeutic area into the following markets: oncology, cardiology, metabolic, neurology, immunology and other applications (such as CNS, respiratory and genetic diseases). Based on end user, it is segmented into biopharmaceutical companies as well as academic research institutions.

The global CRO services market is also segmented by geography into these regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The regional analysis includes a detailed examination of the major countries operating in this market such as the U.S., Germany, the U.K., France, Japan, China and India.

This report analyzes the market trends associated with CRO services using data from 2023, which serves as the base year. Market estimates are provided for 2024, and forecasts of compound annual growth rates are given for the period 2024 through 2029. The report will also highlight the current and future potential of the CRO services market, and will give a detailed analysis of this market's competitive landscape by covering regulatory scenarios, drivers, restraints and opportunities, as well as the market share of key players.

Emerging trends and changing market dynamics within the CRO industry are also analyzed in detail in this report.

This report's goals include:

• Analyzing technologies and applications.
• Analyzing global market size and segmentation.
• Understanding market constraints and drivers.
• Providing detailed market forecasts through 2029.
• Assessing market shares, competitiveness and industry structure.
• Identifying potential long-term impacts on the CRO services market.

Report Includes

• 86 data tables and 33 additional tables
• An overview of the current and future global market for contract research organization (CRO) services
• Analyses of global market trends, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the global CRO market, with market share analysis based on functional services, therapeutic area, end user, and region
• Information on CDISC standards, and regulations on sponsor activities; discussion of the impact of FDA regulations on the pharmaceutical industry and the potential long-term impacts of CROs on the drug discovery technologies market
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
• Profiles of the leading companies, including IQVIA Inc., PPD Inc., ICON plc., Charles River Laboratories International Inc., and LabCorp.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Adoption of AI in CROs
• R&D Investment in Biotech & Pharma Companies
• Rising Prevalence of Chronic and Immunological Diseases Globally
• CROs Add Efficiency
• Market Restraints
• Challenges in CRO Outsourcing
• Shortage of Skilled Professionals
• Market Opportunities
• Inorganic Strategies

Chapter 4 Regulatory Landscape

• FDA Regulation and Impact
• Regulations on Sponsor Activities
• CDISC Standards
• BIMO Program
• European Standards

Chapter 5 Emerging Technologies

• Overview
• Computer-Based Techniques
• Decentralized Clinical Trials
• Advanced Analytics and Simulation

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Global Market CRO Services by Functional Services
• Global Market Size and Forecast
• Clinical Trials
• Preclinical Research
• Drug Discovery
• Central Lab
• Global Market for CRO Services by Therapeutic Area
• Global Market Size and Forecast
• Oncology
• Cardiology
• Metabolic
• Neurology
• Immunology
• Other Applications
• Global Market for CRO Services, by End User
• Global Market Size and Forecast
• Biopharmaceutical Companies
• Academic Research Institutions
• Geographic Breakdown
• Global Market for CRO Services by Region
• Global Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of World

Chapter 7 Competitive Intelligence

• Overview
• Competitive Landscape
• Mergers and Acquisitions
• SWOT Analysis
• Strengths of the Global Market for CRO Services
• Weaknesses of the Global Market for CRO Services
• Opportunities in the Global Market for CRO Services
• Threats to the Global Market for CRO Services

Chapter 8 Sustainability in CRO Services Market: An ESG Perspective

• Introduction to ESG
• Sustainability in the CRO Services Market
• ESG Perspective
• Environmental Impact
• Social Impact
• Governance

Chapter 9 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• CHARLES RIVER LABORATORIES
• FRONTAGE LABS.
• ICON PLC
• IQVIA INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• MEDPACE
• PAREXEL INTERNATIONAL CORP.
• SYNEOS HEALTH
• THERMO FISHER SCIENTIFIC INC.
• WUXI APPTEC